(Q40376836)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7490244%20AND%20SRC:MED&resulttype=core&format=json

19 October 2019

review article

1 reference

title

Chemotherapy in osteosarcoma. Basis for application and antagonism to implementation; early controversies surrounding its implementation (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7490244%20AND%20SRC:MED&resulttype=core&format=json

19 October 2019

author name string

Jaffe N

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7490244%20AND%20SRC:MED&resulttype=core&format=json

19 October 2019

Patel SR

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7490244%20AND%20SRC:MED&resulttype=core&format=json

19 October 2019

Benjamin RS

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7490244%20AND%20SRC:MED&resulttype=core&format=json

19 October 2019

publication date

1 August 1995

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7490244%20AND%20SRC:MED&resulttype=core&format=json

Hematology / Oncology Clinics of North America

19 October 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7490244%20AND%20SRC:MED&resulttype=core&format=json

19 October 2019

volume

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7490244%20AND%20SRC:MED&resulttype=core&format=json

19 October 2019

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7490244%20AND%20SRC:MED&resulttype=core&format=json

19 October 2019

page(s)

825-840

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7490244%20AND%20SRC:MED&resulttype=core&format=json

Primary chemotherapy and delayed surgery for nonmetastatic osteosarcoma of the extremities. Results in 164 patients preoperatively treated with high doses of methotrexate followed by cisplatin and doxorubicin

19 October 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930074-1

7 January 2021

Adriamycin-methotrexate high dose versus adriamycin-methotrexate moderate dose as adjuvant chemotherapy for osteosarcoma of the extremities: a randomized study

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930074-1

7 January 2021

Full-lung tomograms and bone scanning in the initial work-up of patients with osteogenic sarcoma. A review of 126 cases

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930074-1

7 January 2021

A comparison of two short intensive adjuvant chemotherapy regimens in operable osteosarcoma of limbs in children and young adults: the first study of the European Osteosarcoma Intergroup

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930074-1

7 January 2021

Osteosarcoma of the limbs. Report of the EORTC-SIOP 03 trial 20781 investigating the value of adjuvant treatment with chemotherapy and/or prophylactic lung irradiation

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930074-1

7 January 2021

Adjuvant chemotherapy in osteogenic sarcoma: the triumph that isn't?

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930074-1

7 January 2021

Etoposide, cyclophosphamide, cisplatin, and doxorubicin as neoadjuvant chemotherapy for osteosarcoma

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930074-1

7 January 2021

The therapy of osteosarcoma by intraarterial cis-platinum an limb preservation

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930074-1

7 January 2021

Amputation and Adriamycin in Primary Osteosarcoma

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930074-1

7 January 2021

A controlled pilot study of high-dose methotrexate as postsurgical adjuvant treatment for primary osteosarcoma

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930074-1

7 January 2021

Adjuvant chemotherapy for osteosarcoma: a randomized prospective trial

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930074-1

7 January 2021

Adjuvant adriamycin and cisplatin in newly diagnosed, nonmetastatic osteosarcoma of the extremity

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930074-1

7 January 2021

Age and dose of chemotherapy as major prognostic factors in a trial of adjuvant therapy of osteosarcoma combining two alternating drug combinations and early prophylactic lung irradiation. French Bone Tumor Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930074-1

7 January 2021

The therapy of osteogenic sarcoma: Current status and thoughts for the future

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930074-1

7 January 2021

Long-term evaluation of surgery followed by adjuvant adriamycin in osteogenic sarcoma

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930074-1

7 January 2021

Weekly high-dose methotrexate and doxorubicin for osteosarcoma: the Dana-Farber Cancer Institute/the Children's Hospital--study III

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930074-1

7 January 2021

Adjuvant chemotherapy in nonmetastatic osteosarcoma: a Southwest Oncology Group Study

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930074-1

7 January 2021

Adjuvant chemotherapy of osteosarcoma: no runs, no hits, two men left on base

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930074-1

7 January 2021

Pediatric osteosarcoma: therapeutic strategies, results, and prognostic factors derived from a 10-year experience

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930074-1

7 January 2021

Adjuvant methotrexate and citrovorum-factor treatment of osteogenic sarcoma

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930074-1

7 January 2021

Recent advances in the chemotherapy of metastatic osteogenic sarcoma

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930074-1

7 January 2021

Adjuvant chemotherapy in osteogenic sarcoma

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930074-1

7 January 2021

Osteosarcoma: intra-arterial treatment of the primary tumor with cis-diammine-dichloroplatinum II (CDP). Angiographic, pathologic, and pharmacologic studies

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930074-1

7 January 2021

A randomized study comparing high-dose methotrexate with moderate-dose methotrexate as components of adjuvant chemotherapy in childhood nonmetastatic osteosarcoma: a report from the Childrens Cancer Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930074-1

7 January 2021

The effect of adjuvant chemotherapy on relapse-free survival in patients with osteosarcoma of the extremity

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930074-1

7 January 2021

Chemotherapy for nonmetastatic osteogenic sarcoma: the Memorial Sloan-Kettering experience

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930074-1

7 January 2021

A trial of chemotherapy in patients with osteosarcoma (a report to the Medical Research Council by their Working Party on Bone Sarcoma

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930074-1

7 January 2021

Increased survival, limb preservation, and prognostic factors for osteosarcoma

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930074-1

7 January 2021

Adjuvant multiple drug chemotherapy for osteosarcoma of the extremity

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930074-1

7 January 2021

Adjuvant chemotherapy for osteosarcoma of the extremity. Long-term results of two consecutive prospective protocol studies

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930074-1

7 January 2021

Elective whole lung irradiation in the treatment of osteogenic sarcoma

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930074-1

7 January 2021

Preoperative chemotherapy for osteogenic sarcoma:Selection of postoperative adjuvant chemotherapy based on the response of the primary tumor to preoperative chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930074-1

7 January 2021

Response of osteogenic sarcoma to the combination of etoposide and cyclophosphamide as neoadjuvant chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930074-1

7 January 2021

Treatment of osteosarcoma of the extremities with the T-10 protocol, with emphasis on the effects of preoperative chemotherapy with single-agent high-dose methotrexate: a Scandinavian Sarcoma Group study

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930074-1

7 January 2021

Primary Osteosarcoma of Bone: A Clinicopathologic Investigation of 243 Cases, with Necropsy Studies in 54

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930074-1

7 January 2021

Neoadjuvant chemotherapy of osteosarcoma: results of a randomized cooperative trial (COSS-82) with salvage chemotherapy based on histological tumor response

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930074-1

7 January 2021

Neoadjuvant chemotherapy for osteogenic sarcoma: results of a Cooperative German/Austrian study

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930074-1

7 January 2021

10.1016/S0889-8588(18)30074-1

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7490244%20AND%20SRC:MED&resulttype=core&format=json

19 October 2019

1 reference